Transcriptomics

Dataset Information

33

To establish specific structural evidence that glycans are indeed blunted/altered from the glycan profiling of glycan moieties on the surface of leukocytes


ABSTRACT: We want to characterize the glycan moieties on the surface of leukocytes treated with fluorinated analogs of glucosamine. Since these metabolic inhibitors compete with natural-occuring glucosamine used in oligosaccharide chain formation, these compounds have been shown to be effective in lowering Type 2 lactosamine and sialylated Lewis antigens, which results in altered selectin ligand functions. Overall design: We need to establish specific structural evidence that glycans are indeed blunted/altered. Current research efforts include investigations on how circulating leukocytes traffic to inflamed tissues, how circulating solid tumor cells interact with endothelial linings to enhance metastatic potential, and how treatment with analogs of glucosamine disrupt leukocyte trafficking mechanisms and/or influence effector/regulatory function of T cells.

INSTRUMENT(S): [Glyco_v4_Hs] Custom Affymetrix Glyco v4 GeneChip

ORGANISM(S): Homo sapiens  

SUBMITTER: Steven Head  

PROVIDER: GSE32556 | GEO | 2011-10-03

SECONDARY ACCESSION(S): PRJNA147025

REPOSITORIES: GEO

Similar Datasets

2011-10-02 | E-GEOD-32556 | ArrayExpress
2013-01-06 | E-GEOD-32909 | ArrayExpress
| GSE106221 | GEO
2011-01-07 | GSE26480 | GEO
2008-11-21 | GSE11962 | GEO
2008-11-20 | E-GEOD-11962 | ArrayExpress
2011-01-07 | E-GEOD-26480 | ArrayExpress
2008-10-01 | GSE9346 | GEO
2010-06-24 | GSE16800 | GEO
2010-06-24 | E-GEOD-16800 | ArrayExpress